Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Eterna Therapeutics ( (ERNA) ) is now available.
On June 12, 2025, Ernexa Therapeutics Inc. implemented a reverse stock split of its common stock at a ratio of 1-for-15 by filing a certificate of amendment with the Secretary of State of Delaware. This corporate action is likely aimed at consolidating shares to potentially enhance the company’s stock price and improve its market perception.
More about Eterna Therapeutics
Average Trading Volume: 360,017
Technical Sentiment Signal: Strong Sell
Current Market Cap: $9.67M
For a thorough assessment of ERNA stock, go to TipRanks’ Stock Analysis page.